麦德佩斯临床研究 MEDP
$653.11 +$18.13 (+2.86%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $653.11 0.00%
开盘$635.01
昨收$634.98
当日区间$635.00 – $657.77
成交量231.6K
市值$18.27B
市盈率（TTM）36.3
股息率–
财报
财报日平均波动±14.5%近16次财报
收涨次数8 / 1650% 的概率
最佳反应+54.7%
最差反应-22.6%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 21 Oct 2026 | After Market | ±13.8% | -1.29% | 符合区间 |
| 2026/Q2 | 22 Jul 2026 | After Market | ±15.3% | +14.71% | 符合区间 |
| 2026/Q1 | 22 Apr 2026 | After Market | ±14.7% | -22.63% | 超出定价预期 |
| 2025/Q4 | 9 Feb 2026 | After Market | ±11.6% | -15.90% | 超出定价预期 |
| 2025/Q3 | 22 Oct 2025 | After Market | ±14.0% | +9.12% | 符合区间 |
| 2025/Q2 | 21 Jul 2025 | After Market | ±13.7% | +54.67% | 超出定价预期 |
| 2025/Q1 | 21 Apr 2025 | After Market | ±15.8% | -2.32% | 符合区间 |
| 2024/Q4 | 10 Feb 2025 | After Market | ±11.6% | -7.52% | 符合区间 |
| 2024/Q3 | 21 Oct 2024 | After Market | ±15.8% | -7.47% | 符合区间 |
| 2024/Q2 | 22 Jul 2024 | After Market | ±13.0% | -18.27% | 超出定价预期 |
| 2024/Q1 | 22 Apr 2024 | After Market | ±13.4% | +8.21% | 符合区间 |
| 2023/Q4 | 12 Feb 2024 | After Market | ±12.2% | +12.30% | 超出定价预期 |
| 2023/Q2 | 24 Jul 2023 | After Market | ±10.8% | +3.91% | 符合区间 |
| 2023/Q1 | 24 Apr 2023 | After Market | ±12.3% | +11.22% | 符合区间 |
| 2022/Q4 | 13 Feb 2023 | After Market | ±13.1% | -5.12% | 符合区间 |
| 2022/Q3 | 24 Oct 2022 | After Market | ±14.6% | +37.71% | 超出定价预期 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q3, ended Sep 2026
营收$716.00M+8.5% YoY
营业利润$165.54M+16.7% YoY
净利润$137.46M+23.7% YoY
摊薄每股收益$4.84+25.4% YoY
自由现金流$196.44M-16.6% YoY
经营现金流$216.60M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率29.1%
营业利润率21.4%
净利率18.2%
净资产收益率117.9%
资产收益率25.5%
投入资本回报率90.6%
流动比率0.83
负债/资产比率74.6%
现金及投资$705.32M
总负债$146.04M
净现金（净负债）$559.27M
自由现金流/营收23.5%
暂无评论——快来第一个聊聊 MEDP。